TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
大正製薬ホールディングス株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4581
FY2022 · 2023-03-31
| Gross margin | 59.0% |
| Operating margin | 7.6% |
| Net margin | 6.3% |
| Return on equity | 2.6% |
| Return on assets | 2.0% |
| Revenue growth (YoY) | 12.4% |
| EPS (basic) | ¥231.73 |
| EPS growth (YoY) | 43.8% |
| Current ratio | 5.09x |
| Equity ratio | 76.8% |
| Book value / share | ¥9,584.7 |
| Free cash flow | 14,539 M |